HomeLVTX • NASDAQ
add
LAVA Therapeutics NV
Previous close
$0.98
Day range
$0.96 - $0.99
Year range
$0.88 - $6.47
Market cap
25.13M USD
Avg Volume
178.70K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 11.28M | 4.78% |
Net income | -12.30M | -39.16% |
Net profit margin | — | — |
Earnings per share | -0.43 | -38.92% |
EBITDA | -11.17M | -5.62% |
Effective tax rate | -0.79% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 78.88M | -24.60% |
Total assets | 83.36M | -24.92% |
Total liabilities | 50.36M | -10.74% |
Total equity | 32.99M | — |
Shares outstanding | 26.30M | — |
Price to book | 0.78 | — |
Return on assets | -32.12% | — |
Return on capital | -63.88% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -12.30M | -39.16% |
Cash from operations | -8.63M | -21.43% |
Cash from investing | 447.00K | 102.65% |
Cash from financing | -368.00K | 23.65% |
Net change in cash | -8.12M | 67.44% |
Free cash flow | -4.59M | -11.77% |
About
CEO
Founded
2016
Website
Employees
37
